BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home » Authors » John Fox

Articles by John Fox

Synapse discovery could lead to new Alzheimer's treatments

Dec. 3, 2015
By John Fox
HONG KONG — Australian researchers led by the University of New South Wales (UNSW) have discovered the mechanism whereby synaptic connections between brain cells are destroyed in the early stages of Alzheimer's disease (AD), a key finding that clears the way for new research on urgently needed treatments for the currently incurable degenerative brain disease.
Read More

First plasmid-mediated colistin resistance reported in China

Dec. 2, 2015
By John Fox
HONG KONG — A new gene conferring resistance to polymyxins, the last antibiotic defense against resistant microorganisms, has been found to be widespread in Enterobacteriaceae from pigs and patients in southern China, raising fears of emergence of strains of gram-negative bacteria with resistance to all currently available antibiotics.
Read More

First plasmid-mediated colistin resistance reported in China

Dec. 1, 2015
By John Fox
HONG KONG – A new gene conferring resistance to polymyxins, the last antibiotic defense against resistant microorganisms, has been found to be widespread in Enterobacteriaceae from pigs and patients in southern China, raising fears of emergence of strains of gram-negative bacteria with resistance to all currently available antibiotics.
Read More

Protocol converts PSCs into functional neurons

Nov. 25, 2015
By John Fox
HONG KONG — Combining suppression of stemness with lineage-specific induction using a newly developed sequential treatment protocol leads to the successful conversion of pluripotent stem cells (PSCs) into functioning neurons for potential use in regenerative medicine, a study by Korean researchers has found.
Read More

Protocol converts PSCs into functional neurons

Nov. 24, 2015
By John Fox
HONG KONG – Combining suppression of stemness with lineage-specific induction using a newly developed sequential treatment protocol leads to the successful conversion of pluripotent stem cells (PSCs) into functioning neurons for potential use in regenerative medicine, a study by Korean researchers has found.
Read More

New cancer biomarkers set to improve diagnosis and treatment

Nov. 18, 2015
By John Fox
HONG KONG – A new collaborative study by the Riken Center for Life Science Technologies (CLST) in Japan and the Harry Perkins Institute for Medical Research in Australia has identified multiple new genes that are up-regulated in different cancer types, opening the door for the development of new biomarker tests for early cancer detection and more effective new treatments.
Read More

Potential new neuroblastoma treatment identified

Nov. 18, 2015
By John Fox
HONG KONG – An Australian study has identified a critical molecular feedback loop that helps initiate and drive neuroblastoma, which may result in a badly needed new treatment strategy for the disease, Sydney Children's Hospital and University of New South Wales (UNSW) researchers reported in the Nov. 4, 2015, issue of Science Translational Medicine.
Read More

Potential new neuroblastoma treatment identified

Nov. 12, 2015
By John Fox
HONG KONG – An Australian study has identified a critical molecular feedback loop that helps initiate and drive neuroblastoma, which may result in a badly needed new treatment strategy for the disease, Sydney Children’s Hospital and University of New South Wales (UNSW) researchers reported in the Nov. 4, 2015, issue of Science Translational Medicine.
Read More

First mouse model of spontaneous depression reveals new brain region

Oct. 28, 2015
By John Fox
HONG KONG — Japanese neurobiologists have used a mouse model of spontaneous depression to demonstrate a link between depression and the paraventricular thalamus, a region of the brain not previously linked to depression, a finding that could lead to the development of new antidepressive therapies.
Read More

First mouse model of spontaneous depression reveals new brain region

Oct. 27, 2015
By John Fox
HONG KONG — Japanese neurobiologists have used a mouse model of spontaneous depression to demonstrate a link between depression and the paraventricular thalamus, a region of the brain not previously linked to depression, a finding that could lead to the development of new antidepressive therapies.
Read More
Previous 1 2 … 50 51 52 53 54 55 56 57 58 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing